Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0011570 (depression)
 172,036 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

By the method of transesophageal electrostimulation of the left auricle, 98 patients with Leriche's syndrome were examined. Of them in 51, the coronary disease was revealed. The degree of ischemic changes in the terminal part of the ventricular complex were defined by the rate of stimulation, depth of the ST segment shift, and duration of ischemic depression. The nitroglycerin test permitted to evaluate the anti-ischemic effect of the drug, quality and effectiveness of the preoperative preparation. In patients with negative or doubtful anti-ischemic effect, the risk of the development of cardiac complications increases.
 ...
PMID:[Use of transesophageal electrostimulation of the atrium and nitroglycerin test in the evaluation of the degree of risk of the development of cardiac complications after reconstructive surgery in patients with Leriche's syndrome]. 250 20

The efficacy of transdermal nitroglycerin patches, releasing 20 mg of active substance over a period of 24 h (TDN 20), was investigated in 10 patients with stable exercise-induced angina pectoris. The study was divided into 3 periods: the first part was an acute, within-patient, crossover, double-blind, placebo-controlled study, in which patients performed a cycloergometric exercise test 4 and 24 h after the application of the patches (TDN 20 or placebo). During the 2nd period, patients were given TDN 20, in single blind conditions, for 4 weeks and another exercise test was performed, on the last day, 4 and 24 h after patch application. Finally, after a one-day placebo wash-out, a second acute study similar to the first was performed. Four h after dosing, exercise duration to 1 mm ST segment depression was 441 s and 314 s (p less than 0.01) for TDN 20 and placebo, respectively (first acute study), 394 s for TDN 20 after chronic treatment (p less than 0.001 vs acute placebo) and 472 and 354 s (p less than 0.001) for TDN 20 and placebo, respectively (second acute study). No difference in exercise duration to 1 mm ST segment depression was found between TDN 20 and placebo, 24 h after administration, in any of the periods. Blood pressure significantly decreased and heart rate significantly increased 4 h after TDN dosing (in comparison with placebo) in both the acute studies, but no difference was observed after chronic TDN treatment. In conclusion, TDN 20 increases exercise tolerance 4 h after the application of both acute and chronic treatments.(ABSTRACT TRUNCATED AT 250 WORDS)
 ...
PMID:Chronic effects of transdermal nitroglycerin in stable angina pectoris: a within-patient, placebo-controlled study. 250 80

Peripheral perfusion abnormalities are considered a possible reason for myocardial ischemia in the absence of visible coronary artery stenoses. In 85 women (age: 41-58 years, mean age: 46 +/- 8) with pathological exercise ECG (precordial mapping: 50 leads), hemodynamic studies were performed without medication, after sublingual nitroglycerin (NTG, 0.8 mg), sublingual Nifedipin (N, 30 mg), and intravenous Dipyridamol (D, 0.5 mg/kg). Eighteen women showed normal coronary arteries and a normal myocardial perfusion (group I), 21 an impaired perfusion due to coronary stenoses (Group II), and 46 women a reduced perfusion without visible changes (Group III). Reference methods were measurement of pulmonary artery pressure, 201-TI-scintigraphy, and coronary angiography. In group II, enddiastolic and endsystolic left ventricular volume (EDV, ESV) as well as enddiastolic pulmonary artery pressure (pAd) were increased, the ejection fraction (EF) was reduced, and cardiac output (CO) was normal. In group III, ESV, EDV, EF, and CO were significantly reduced, while pAd increased. In group II, N led to a normalization of ESV, EDV, EF, and pAd. In group III, NTG led to a reduction of pAd and EDV, and concomitantly to a further reduction of the already low CO. In both groups the reduction of ST-segment depressions after NTG was significant. N led to a moderate reduction of pAd and ST-segment depression, but to an increase of CO in both groups. D exhibited a comparable effect in group III. In group II an increase of ST-segment changes and of pAd with unchanged CO was observed. With regard to longterm treatment of women in group III, N and D seemed to be more efficacious than nitrates due to a beneficial effect on cardiac output.
 ...
PMID:[Differential therapy of myocardial ischemia in females]. 251 81

Fourteen patients with typical exercise-induced angina and ST-segment depression received 0.025 mg nitroglycerin intravenously or placebo directly before exercise testing in a double-blind cross-over study. The sum of ST-segment depressions during stress and recovery was 12.8 +/- 4.8 mm after placebo and 8.9 +/- 4.6 mm after nitroglycerin (p less than 0.001). The symptom-free exercise time increased from 3.1 +/- 1.4 to 4.3 +/- 1.9 min (p less than 0.1), whereas severity of angina during exercise decreased significantly (p less than 0.05) after nitroglycerin. There was no influence on either heart rate or blood pressure. In a second randomized double-blind study, 40 patients with coronary heart disease received either 0.025 mg nitroglycerin or placebo intravenously. Before and 2 min after injection the aortic and left ventricular pressures were recorded and coronary angiography was performed. Mean heart rate, blood pressure, left ventricular filling pressure and pre- and poststenotic coronary artery diameter, as well as the diameters of representative distal coronary artery segments showed no significant changes. Coronary artery stenosis diameters remained unchanged after placebo, but increased significantly after nitroglycerin from 1.15 +/- 0.68 to 1.32 +/- 0.73 mm (p less than 0.01). It can be hypothesized from these results that dilatation of coronary stenosis plays an important role in the antianginal action of nitroglycerin. Coronary artery stenoses seem to be more sensitive to nitroglycerin than are other vessel segments.
 ...
PMID:[Anti-angina and coronary dilating effect of low-dose nitroglycerin]. 251 93

In 24 patients (pts) with proven coronary artery disease, stable angina pectoris (AP) and elevated pulmonary artery pressure (PAP) during bicycle exercise, the acute and chronic (4 and 8 months) effects of several long-acting nitrates in different dosages: 50-300 mg pentaerythrityltetranitrate (PETN) or 40-120 mg isosorbide dinitrate (ISDN) were evaluated in comparison to sublingual nitroglycerin. Nitroglycerin was about 30%-40% more effective than PETN and ISDN with regard to pulmonary artery pressure at exercise. Beneficial effects of both long-acting nitrates were shown with regard to the number of anginal attacks, nitroglycerin consumption, and ST-segment depression both during short- and long-term treatment. Both nitrates decreased exercise pulmonary artery pressure by 15%-20%, at acute testing and during chronic therapy. There was no difference with respect to the long-term effects of both long-acting nitrates. However, more side-effects were observed during ISDN treatment. There were no signs of nitrate tolerance development with the therapy schedules under investigation.
 ...
PMID:[Long-term effect of various nitrates in ischemic heart disease and latent heart failure]. 251 96

The antianginal effects of propranolol 160 mg/day, diltiazem 240 mg/day, nicardipine 80 mg/day, nifedipine 40 to 80 mg/day and verapamil 320 mg/day were compared in 12 patients with chronic stable angina pectoris using a symptom-limited exercise test. Compared to placebo propranolol and calcium antagonists similarly reduced (p less than 0.001) the frequency of antianginal attacks and nitroglycerin consumption, and increased exercise tolerance and time to greater than or equal to 1 mm S-T segment depression. After propranolol the pressure-rate product at submaximal and maximal exercise was significantly decreased. The calcium antagonists produced a significant reduction in the submaximal pressure-rate product, but no significant change in the peak pressure-rate product. Maximum ST depression was significantly lower after propranolol and was unchanged after the calcium antagonists. None of the drugs caused significant adverse effects. The results indicate that in patients with stable effort angina pectoris, diltiazem, nicardipine, nifedipine and verapamil were as effective as propranolol in improving exercise tolerance and time to ischaemia, and they did not alter the peak pressure-rate product. Different antianginal mechanisms may be operative for the various calcium antagonists.
 ...
PMID:Comparison of the antianginal efficacy of four calcium antagonists and propranolol in stable angina pectoris. 251 6

It is well known that vasodilating antihypertensive drugs induce intracranial hypertension. A considerable number of papers have reported nitroglycerin-induced ICP elevation during anesthetized operations. However, except for Gagnon's report, most papers dealt with normal patients. Our study, using an extradural pressure transducer clinically, deals with the nitroglycerin drip infusion and its effect on high ICP state. Mean ICP value before infusion was 42 mmHg+ 14.8 (N = 10). Three cases out of ten showed ICP elevation corresponding with blood pressure depression. Six cases out of ten revealed ICP depression corresponding with blood pressure depression. One case did not show any difference in ICP. There was a statistically significant difference between the ICP elevated group and the depressed group. These results suggest that very high ICP state, like vasomotor paralysis, does not have a potential to open the vascular bed in the cranium and blood pressure depression induced by nitroglycerin infusion causes ICP depression. We would like to conclude that nitroglycerin can be used for postoperative blood pressure control even in the neurosurgical field.
 ...
PMID:[Post-operative blood pressure management by nitroglycerin in the field of neurosurgery]. 251 60

Transdermal nitroglycerin becomes more and more common mode of pharmacotherapy as this form of nitroglycerin ensures permanent therapeutic level of the drug in the blood serum for a long time. The largest clinical experience with transdermal nitroglycerin has been gathered in effort angina although it is used in all forms of ischemic heart disease. It has been documented that transdermal nitroglycerin improves exercise tolerance, increases pain threshold, delays the onset of ST segment depression in the ECG and decreases the incidence of anginal attacks. Beneficial effects of transdermal nitroglycerin on hemodynamic parameters have been shown also in patients with myocardial infarction, especially complicated by heart failure. First results obtained in the treatment of silent myocardial ischemia are very promising. The development of tolerance requires 12-hour intervals in the use of nitroglycerin patches.
 ...
PMID:[Transdermal use of nitroglycerin]. 251 62

The efficacy of nitroglycerin ointment was determined by treadmill exercise testing through a randomized, double-blind crossover trial with placebo in 22 patients with chronic stable exertional angina. On different days, 3 cm of nitroglycerin ointment (NGO, 18 mg) and placebo ointment were applied over the epigastric region, followed by the exercise test 1 hour later. The maximal exercise time was 459 +/- 124 seconds after application of placebo and 510 +/- 113 seconds after application of NGO, and the exercise time to 1 mm of ST-segment depression was significantly extended to 297 +/- 110 seconds after placebo and 366 +/- 134 seconds after NGO (p less than 0.01, p less than 0.001, respectively). ST-segment depression at the endpoint of exercise was significantly reduced from 2.4 +/- 1.2 mm to 1.5 +/- 0.7 mm after application of NGO (p less than 0.01). There was no difference in rate-pressure product at the endpoint of exercise between placebo and NGO. Adverse reactions were elicited in 5 of 22 patients. The results of this present study suggest that NGO is effective in the treatment of exertional angina.
 ...
PMID:The effect of nitroglycerin ointment on exercise-induced angina: a multicenter trial. 251 79

False-positive responses to exercise tests have been reported as been more frequent in athletes than in the general population and attributed to physiological hypertrophy of the athlete's heart. In this study, we have investigated the significance of major ST depression (-3.55 +/- 1.8 mm) in a group of 13 athletes aged 40 +/- 9 years who had normal coronary angiography. All subjects underwent a standard exercise test followed by a second one after administration of nitroglycerin; the post-test probability of coronary was evaluated by multivariate analysis of the results. Myocardial perfusion was studied in 9 subjects by stress thallium 201 scintigraphy, and the data obtained were compared with those of angiography. Left ventricular hypertrophy was systematically looked for by calculating the myocardial mass index at echocardiography. The subjects were also investigated for possible alteration of the diastolic function, using doppler ultrasound. The mean follow-up period was 5 +/- 2 years. The mean performance at exercise tests was 238 +/- 118 watts. The Q wave significantly increased at exercise (-0.61 +/- 0.8; p less than 0.05), whereas the R wave remained constant (-0.95 +/- 4.5 mm; N.S.). The mean probability or coronary disease was 0.49 +/- 0.41, which justified the thallium scintigraphy test. This test was abnormal in 8 out of 9 cases. The myocardial mass index was slightly increased up to 138 +/- 25 g/m2, reflecting a very moderate physiological hypertrophy, as testified by the normality of diastolic function related to age in 8/9 cases. There was no obvious correlation between ST depression amplitude and myocardial mass index.(ABSTRACT TRUNCATED AT 250 WORDS)
 ...
PMID:[Contribution of Doppler echocardiography and thallium in cases of major ST segment depression in athletes]. 253 Sep 58


<< Previous 1 2 3 4 5 6 7 8 9 10